About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company dedicated to transforming the treatment landscape for central nervous system (CNS) disorders. Our commitment to delivering scientific innovations allows us to identify crucial gaps in patient care. We focus on developing unique therapies that leverage novel mechanisms of action, significantly enhancing patient outcomes. Our extensive neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, as well as migraine treatments. We are also advancing multiple late-stage development programs aimed at addressing a wide range of serious neurological and psychiatric disorders that affect over 150 million individuals in the United States. Our mission is to tackle some of the most pressing challenges in CNS healthcare, ensuring that patients and their families can thrive.

